Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Applications of fdg pet in oncology : best clinical practice / / edited by Hirofumi Fujii, Hiroyuki Nakamura, Seiei Yasuda
| Applications of fdg pet in oncology : best clinical practice / / edited by Hirofumi Fujii, Hiroyuki Nakamura, Seiei Yasuda |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (VII, 147 p. 61 illus., 55 illus. in color.) |
| Disciplina | 660.05 |
| Soggetto topico |
Cancer - Tomography
Oncology Tomography, Emission |
| ISBN | 981-15-8423-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1 Overview.-2 Lung cancer.-3 Breast cancer -- 4 Head and neck cancer.-5 Gastrointestinal cancer including GIST -- 6 Pancreatic cancer -- 7 Urological cancer -- 8 Malignant bone and soft tissue tumors -- 9 Skin cancer including malignant melanoma -- 10 Malignant lymphoma. |
| Record Nr. | UNINA-9910484814103321 |
| Singapore : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chronic Obstructive Pulmonary Disease : A Systemic Inflammatory Disease / / edited by Hiroyuki Nakamura, Kazutetsu Aoshiba
| Chronic Obstructive Pulmonary Disease : A Systemic Inflammatory Disease / / edited by Hiroyuki Nakamura, Kazutetsu Aoshiba |
| Edizione | [1st ed. 2017.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2017 |
| Descrizione fisica | 1 online resource (XI, 352 p. 64 illus., 27 illus. in color.) |
| Disciplina | 616.24 |
| Collana | Respiratory Disease Series: Diagnostic Tools and Disease Managements |
| Soggetto topico |
Respiratory organs—Diseases
Pneumology/Respiratory System |
| ISBN | 981-10-0839-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I Definition and Epidemiology -- 1.Definition of COPD -- 2.Epidemiology of COPD -- Part II Genetic Predisposition and Pathogenic Mechanisms -- 3.Genetic predisposition to COPD -- 4.Pathogenesis of COPD—Persistence of airway inflammation -- 5.Pathogenesis of COPD 3- Oxidative stress -- 6.Pathogenesis of COPD 4 -- Part III Comorbidities -- 7.Pathogenesis of comorbidities in COPD -- 8.Assessment of inflammation in COPD -- Part IV Management and Treatment -- 9.Exercise therapy for COPD -- 10.Nutritional therapy for COPD -- 11.Home oxygen therapy for COPD -- 12.Bronchodilators for COPD -- 13.Inhaled corticosteroids for COPD -- 14.New anti-inflammatory drugs for COPD -- 15.Exacerbation of COPD -- Part V Associations with other Respiratory Diseases -- 16.Asthma-COPD overlap syndrome (ACOS) -- 17.Combined pulmonary fibrosis and emphysema (CPFE) -- 18.Association of COPD and lung cancer. |
| Record Nr. | UNINA-9910148786803321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug-Induced Lung Injury / / edited by Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba
| Drug-Induced Lung Injury / / edited by Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba |
| Edizione | [1st ed. 2018.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2018 |
| Descrizione fisica | 1 online resource (VIII, 215 p. 53 illus., 15 illus. in color.) |
| Disciplina | 617.13 |
| Collana | Respiratory Disease Series: Diagnostic Tools and Disease Managements |
| Soggetto topico |
Respiratory organs—Diseases
Pneumology/Respiratory System |
| ISBN | 981-10-4466-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I Definition, Pathogenesis, and Epidemiology -- 1. Definition, Pathogenesis and Epidemiology: What is DLI? -- 2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI? -- 3. Clinical Characteristics of DLI: What are the clinical features of DLI? -- Part II Diagnosis -- 4. Diagnostic Approach for DLI: How is DLI diagnosed? -- 5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI? -- 6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted? -- 7. Pathology of DLI: What is the pathological significance of DLI? -- 8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI? -- Part II Treatment -- 9. Therapeutic Strategies for DLI: How should DLI be treated? -- Part IV Drugs Causing DLI -- 10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs? -- 11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs? -- 12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs? -- 13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines? -- 14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs?. |
| Record Nr. | UNINA-9910300455003321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Idiopathic Pulmonary Fibrosis : Advances in Diagnostic Tools and Disease Management / / edited by Hiroyuki Nakamura, Kazutetsu Aoshiba
| Idiopathic Pulmonary Fibrosis : Advances in Diagnostic Tools and Disease Management / / edited by Hiroyuki Nakamura, Kazutetsu Aoshiba |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Tokyo : , : Springer Japan : , : Imprint : Springer, , 2016 |
| Descrizione fisica | 1 online resource (260 p.) |
| Disciplina | 610 |
| Soggetto topico |
Respiratory organs—Diseases
Cytokines Growth factors Pneumology/Respiratory System Cytokines and Growth Factors |
| ISBN | 4-431-55582-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part 1 -- Definition, epidemiology, and pathogenesis -- Chapter 1: Definition of IPF (Question: Is the latest classification [ATS/ERS] satisfactory?) -- Chapter 2: Epidemiology and risk factors of IPF (Question: Can we dare to ask, “What are the possible causes?”) -- Chapter 3: Acute exacerbation of IPF (Question: The concept was proposed in Japan, but why was it not recognized in western countries?) -- Chapter 4: Pathogenesis (Question: Is abnormal repair of epithelial damage involved in the basic pathogenesis of this disease?) -- Part 2 Diagnosis -- Chapter 5: Specific serum markers of IPF (Question: What are the significances of KL-6, SP-A, and SP-D?) -- Chapter 6: High-resolution CT of honeycombing and IPF/UIP (Question: To what extent can honeycomb lung be diagnosed by imaging? To what extent can IPF diagnosis be made by HRCT?) -- Chapter 7: Pathology of IPF (Question: Why does the pathological classification of IIPs vary among pathologists?) -- Chapter 8: Differential diagnosis (Question: What should we particularly keep in mind in the differential diagnosis?) -- Part 3 Management and prognosis -- Chapter 9 Pharmacotherapy of IPF (antifibrotic compounds) (Question: Can antifibrotic agents really inhibit fibrosis? How about the development of new therapeutic agents?) -- Chapter 10: Pharmacotherapy of IPF (Corticosteroids, immunosuppressants) (Question: Are these actually effective? Ineffective? Harmful?) -- Chapter 11: Non-pharmacological therapy for IPF (Question: Is respiratory care actually effective?) -- Chapter 12: Pharmacotherapy of acute exacerbation of IPF (Corticosteroids, immunosuppressants and direct hemoperfusion with polymyxin B) (Question: Are high-dose steroid therapy, other immunosuppressant therapy, and PMX therapy [often used in Japan] really effective?) -- Part 4 Topics -- Chapter 13 :Combined pulmonary fibrosis and emphysema (CPFE) (Question: Is it an independent disease entity?) -- Chapter 14: Common pathways in IPF and lung cancer (Question: Why is lung cancer associated with IPF at a high frequency?) -- Chapter 15 :Acute exacerbation of IIPs after pulmonary resection for lung cancer (Question: Can acute exacerbation of IPF be predicted preoperatively?) . |
| Record Nr. | UNINA-9910254511703321 |
| Tokyo : , : Springer Japan : , : Imprint : Springer, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||